Author/Authors :
Giovanni Persico, Marco Policlinico San Matteo - Nuclear Medicine Unit - Pavia, Italy , Marenco, Manuela Policlinico San Matteo - Nuclear Medicine Unit - Pavia, Italy , De Matteis, Gianluca Policlinico San Matteo - Nuclear Medicine Unit - Pavia, Italy , Manfrinato, Giulia Policlinico San Matteo - Nuclear Medicine Unit - Pavia, Italy , Cavenaghi, Giorgio Policlinico San Matteo - Nuclear Medicine Unit - Pavia, Italy , Sgarella, Adele Policlinico San Matteo - Breast Cancer Unit - Pavia, Italy , Aprile, Carlo National Center for Oncological Hadrontherapy (CNAO) - Pavia, Italy , Lodola, Lorenzo Policlinico San Matteo - Nuclear Medicine Unit - Pavia, Italy
Abstract :
Recent developments in sentinel lymph node (SLN) and radio occult lesion localization (ROLL) highlight the need for a
multimodal contrast agent, providing better presurgical PET imaging and improved intraoperative mapping thanks to fluorescence detection. For this reason, we have studied a trimodal SLN/ROLL targeting agent (99mTc-68Ga-ICG) with commercially
available kits of macroaggregated or nanocolloidal albumin (MA/NC-HSA). 68Ga PET imaging does provide better spatial
resolution and makes it possible to predict signal intensity during surgery. The presence of 99mTc assesses the ecacy of these
compounds in vitro and also during the surgery procedure. The aim of this study was to optimise the labelling and tagging of these
two radiopharmaceuticals and assess their yields and stability. Kits of MA/NC-HSA particles (Pulmocis® and NanoAlbumon®)
were used for sequential radiolabelling with 99mTc and 68Ga. Fluorescent tagging was performed using indocyanine green, a
tricarbocyanine dye. The ITLC radiochemical purity of the trilabelled MA/NC-HSA was >95%. Fluorescent purity was measured
by scanning the strips with a PhotoDynamicEye probe. Finally, in vitro stability tests, performed with DTPA and human serum
solutions, assessed the ecacy of fluorescent tagging and radiolabelling.
Keywords :
ROLL , Trimodal , PET , SLN